[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics. image

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.

Immunotherapy (CAR T, Bispecifics and more) Treatment
event Aug 20, 2024 / 06:00PM - 07:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Elranatamab is a new treatment option that we will explore with Dr. Alex Lesokhin. Come learn how it works; how it compares to other bispecifics; and who might benefit from this new treatment option.

 

Schedule & Agenda

The panelist Cynthia Cahoon
Introductions
6:00 PM
Cynthia Cahoon

Cynthia introduces the agenda of the event and featured speaker Dr. Alex Lesokhin

The panelist Dr. Alexander Lesokhin
Presentation
6:05 PM
Dr. Alexander Lesokhin

Dr. Alex Lesokhin talks about Elranatamab

person
Questions and Answers
6:35 PM
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon
Cynthia Cahoon

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Dr. Alexander Lesokhin
Dr. Alexander Lesokhin

Alexander Lesokhin, MD, is a Hematologic Oncologist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, NY, who specializes in myeloma and immunology. His research work involves developing innovative ways to use the immune system to treat cancer. He conducts clinical studies of medicines that enhance the immune response as well as laboratory studies aimed at understanding how cancers such as multiple myeloma are able to evade the immune response with a goal of developing new ways to treat myeloma patients. Dr. Lesohkin completed his fellowship at MSKCC and his residency at New York-Presbyterian Hospital/Columbia University Medical Center. He earned his medical degree at the Albert Einstein College of Medicine in New York.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.